Morgan Stanley’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.48M | Buy |
3,398,171
+1,165,916
| +52% | +$3.25M | ﹤0.01% | 3493 |
|
2025
Q1 | $8.01M | Buy |
2,232,255
+649,786
| +41% | +$2.33M | ﹤0.01% | 3540 |
|
2024
Q4 | $4.98M | Buy |
1,582,469
+68,246
| +5% | +$215K | ﹤0.01% | 4001 |
|
2024
Q3 | $4.27M | Buy |
1,514,223
+326,101
| +27% | +$920K | ﹤0.01% | 4082 |
|
2024
Q2 | $1.46M | Buy |
1,188,122
+403,650
| +51% | +$496K | ﹤0.01% | 4753 |
|
2024
Q1 | $623K | Sell |
784,472
-844,808
| -52% | -$671K | ﹤0.01% | 5210 |
|
2023
Q4 | $1.55M | Buy |
1,629,280
+481,984
| +42% | +$459K | ﹤0.01% | 5080 |
|
2023
Q3 | $1.24M | Sell |
1,147,296
-517,357
| -31% | -$559K | ﹤0.01% | 4674 |
|
2023
Q2 | $1.49M | Buy |
1,664,653
+476,570
| +40% | +$428K | ﹤0.01% | 4603 |
|
2023
Q1 | $1M | Buy |
1,188,083
+125,489
| +12% | +$106K | ﹤0.01% | 4855 |
|
2022
Q4 | $988K | Sell |
1,062,594
-331,476
| -24% | -$308K | ﹤0.01% | 4877 |
|
2022
Q3 | $2.37M | Buy |
1,394,070
+150,518
| +12% | +$256K | ﹤0.01% | 4304 |
|
2022
Q2 | $2.66M | Sell |
1,243,552
-142,580
| -10% | -$305K | ﹤0.01% | 4314 |
|
2022
Q1 | $4.92M | Sell |
1,386,132
-615,657
| -31% | -$2.19M | ﹤0.01% | 3703 |
|
2021
Q4 | $7.45M | Buy |
2,001,789
+335,557
| +20% | +$1.25M | ﹤0.01% | 3288 |
|
2021
Q3 | $12.3M | Buy |
1,666,232
+844,347
| +103% | +$6.24M | ﹤0.01% | 2649 |
|
2021
Q2 | $10.9M | Buy |
821,885
+705,532
| +606% | +$9.4M | ﹤0.01% | 2870 |
|
2021
Q1 | $879K | Sell |
116,353
-337,410
| -74% | -$2.55M | ﹤0.01% | 4815 |
|
2020
Q4 | $7.61M | Buy |
453,763
+128,511
| +40% | +$2.15M | ﹤0.01% | 2807 |
|
2020
Q3 | $4.05M | Buy |
+325,252
| New | +$4.05M | ﹤0.01% | 2917 |
|